CCK in animal and human research on anxiety

This publication has 27 references indexed in Scilit:

• The anxiogenic effects of CCK-4 in monkeys are reduced by CCK-B antagonists, benzodiazepines or adenosine A2 agonists
  European Neuropsychopharmacology, 1992
• Cholecystokinin-dopamine intearctions
  Trends in Pharmacological Sciences, 1991
• Cholecystokinin-induced anxiety: How is it reflected in studies on exploratory behaviour?
  Neuroscience & Biobehavioral Reviews, 1991
• The behavioural properties of CI‐988, a selective cholecystokinin_B receptor antagonist
  British Journal of Pharmacology, 1991
• Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys
  Neuropeptides, 1991
• Cholecystokinin Antagonists
  Annual Review of Pharmacology and Toxicology, 1991
• Facilitatory effects of caerulein on hypothalamic defensive attack in cats
  Brain Research, 1988
• Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats
  European Journal of Pharmacology, 1984
• Cholecystokinin Octapeptide: Continuous Picomole Injections Into the Cerebral Ventricles of Sheep Suppress Feeding
  Science, 1979
• New peptide in the vertebrate CNS reacting with antigastrin antibodies
  Nature, 1975